Real-time enrollment status for this hyperkalaemia clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 7:59 AM UTC
| NCT Number | NCT03813407 |
| Recruiting Status | Recruiting |
| Condition | Hyperkalaemia |
| Phase | PHASE3 |
| Target Enrollment | 140 participants |
| Active Locations | 14 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of July 19, 2026: Clinical trial NCT03813407 is currently recruiting participants. This phase3 study for hyperkalaemia is actively seeking new participants at 14 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03813407 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03813407 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.